{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:33:23Z","timestamp":1761863603361,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jcin.2016.04.035","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T15:17:46Z","timestamp":1469719066000},"page":"1652-1663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mid- to Long-Term Clinical Outcomes of\u00a0Patients Treated With the Everolimus-Eluting Bioresorbable Vascular\u00a0Scaffold"],"prefix":"10.1016","volume":"9","author":[{"given":"Cordula M.","family":"Felix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang Ming","family":"Fam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Diletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Karanasos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert R.C.","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas M.D.A.","family":"van Mieghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.T.","family":"de Jaegere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn S.","family":"Regar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert-Jan M.","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2016.04.035_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.04.035_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"Raber","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.04.035_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.04.035_bib4","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2014.09.029","article-title":"OCT Assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold","volume":"64","author":"Karanasos","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.04.035_bib5","first-page":"996","article-title":"Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities","volume":"11","author":"Simsek","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial","volume":"6","author":"Onuma","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.04.035_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2016.04.035_bib8","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A\u00a0randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.04.035_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4244\/EIJY14M12_10","article-title":"Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds","volume":"11","author":"Wohrle","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib11","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.04.035_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1540-8183.2012.00766.x","article-title":"Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study","volume":"25","author":"Hermiller","year":"2012","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jcin.2016.04.035_bib13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","article-title":"The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled","volume":"10","author":"Abizaid","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4244\/EIJY14M08_08","article-title":"Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry","volume":"10","author":"Kraak","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4244\/EIJY14M09_08","article-title":"Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients","volume":"11","author":"Ishibashi","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib16","doi-asserted-by":"crossref","first-page":"V181","DOI":"10.4244\/EIJV11SVA43","article-title":"What about the risk of thrombosis with bioresorbable scaffolds?","volume":"11","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12471-015-0651-3","article-title":"Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands","volume":"23","author":"Everaert","year":"2015","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jcin.2016.04.035_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4244\/EIJY15M01_05","article-title":"Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective","volume":"11","author":"Tamburino","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002369","article-title":"Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience","volume":"8","author":"Karanasos","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.04.035_bib20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.04.035_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4244\/EIJV6I9A182","article-title":"First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography","volume":"6","author":"Okamura","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.04.035_bib22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10554-012-0016-6","article-title":"In\u00a0vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography","volume":"28","author":"Tu","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcin.2016.04.035_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.hlc.2015.02.011","article-title":"Everolimus-eluting bioresorbable vascular scaffold implantation in real world and complex coronary disease: procedural and 30-day outcomes at two Australian centres","volume":"24","author":"Robaei","year":"2015","journal-title":"Heart Lung Circ"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816304885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816304885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:04:12Z","timestamp":1761847452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879816304885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1936879816304885"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2016.04.035","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mid- to Long-Term Clinical Outcomes of\u00a0Patients Treated With the Everolimus-Eluting Bioresorbable Vascular\u00a0Scaffold","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2016.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier","name":"copyright","label":"Copyright"}]}}